Both companies also market their drugs directly to cash-paying patients at reduced prices, with tirzepatide starter doses available for around $299 per month** and additional doses up to **$449 per month
More product approvals are showing up, and demand keeps increasing for options that feel more patient friendly, and that combination keeps pushing the growth of oral GLP-1 treatments across countries
Patients who combine GLP-1 medications with resistance training preserve significantly more muscle than those relying on diet and medication alone
Tafuri A, Lemoli RM, Chen R, Gulati SC, Clarkson BD, Mandelli F, Andreeff M
Afzal is a members of the Abiomed Speakers Bureau
PLoS One 4 , e7584 (2009)